The course of diagnosis in autistic patients: The delay between recognition of the first symptoms by parents and correct diagnosis

Neuroendocrinology Letters

Volumn 28, Issue 6, 2007, Pages 895-900

  Ošlejšková, Hana ^a   Kontrová, Ivana ^b   Foralová, Renata ^b   Dušek, Ladislav ^b   Némethová, Danka ^b  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Age at diagnosis; Asperger's syndrome; Autism; Behavioural therapy; Early symptoms; Education

Indexed keywords

AGE DETERMINATION; ARTICLE; ASPERGER SYNDROME; AUTISM; CHILD HEALTH CARE; CLINICAL FEATURE; COGNITION; DELAYED DIAGNOSIS; EARLY DIAGNOSIS; EARLY INTERVENTION; FEMALE; HUMAN; INFANT; INFANTILE AUTISM; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENTAL PERFORMANCE; ONSET AGE; PARENTAL ATTITUDE; PRESCHOOL CHILD; PROBLEM IDENTIFICATION; SCHOOL CHILD;

EID: 37849023568     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Allen DA. Autistic spectrum disorders: clinical presentation in preschool children. J Child Neurol. 1988; 3: S48.
2. Anagnostou E, Schevell M. Outcomes of children with autism In: Tuchman R, Rapin I, editors. Autism: A neurological disorder of early brain development. London: Mac Keith Press; 2006. p.308-21.
3. Attwood T. Asperger's Syndrome: A Guide for Parents and Professionals. London: Jessica Kingsley Publishers; 1998.
4. Baghdadli A, Picot MC, Pascal C, Pry R, Aussilloux C. Relationship between age of recognition of first disturbances and severity in young children with autism. Eur Child Adolesc Psychiatry. 2003 Jun; 12(3): 122-7.
5. Baird G, Charman T, Baron-Cohen S, et al. A screening instrument for autism at 18 months of age: A 6-year follow-up study. J Am Acad Child Adolesc Psychiatry. 2000; 39: 694-702.
6. Buitelaar JK. Why have drug treatments been so disappointing? In: Novartis Foundation. Autism: Neural basis and treatment possibilities. John Willey & Sons Ltd; 2003. p.235-49.
7. Charman T. Epidemiology and early identification of autism: research challenges and opportunities. In: Novartis Foundation. Autism: Neural basis and treatment possibilities. John Willey & Sons Ltd; 2003. p.10-25.
8. Coleman ME. The neurology of Autism. New York: Oxford University Press; 2005.
9. Croonenberghs J, Wauters A, Deboutte D, Verkerk R, Scharpe S, Maes M. Central serotonergic hypofunction in autism: results of the 5-hydroxy-tryptophan challenge test. Neuroendocrinol Lett. 2007 Aug; 28(4): 449-55.
10. Dawson G, Zanolli K. Early intervention and brain plasticity in autism. In: Novartis Foundation. Autism: Neural basis and treatment possibilities. John Willey & Sons Ltd; 2003. p.266-88.
11. Filipek PA. Autistic spectrum disorders. In: Swaiman KF, Ashwal S. Pediatric neurology. Principles & Practice. St. Louis: Mosby Inc. 1999; 606-628.
12. Folstein SE, Dowd M, Mankoski R, Tadevosyan O. How might genetic mechanisms operate in autism? In: Novartis Foundation. Autism: Neural basis and treatment possibilities. John Willey & Sons Ltd; 2003. p.70-83.
13. Fombonne E. Epidemiologic studies of the pervasive developmental disorders. In: Volkmar FR, Paul R, Kim A, Cohen D, editors. Handbook of Autism and Pervasive Developmental Disorders. 3rd ed. New York: John Wiley; 2005. p.42-69.
14. Geier DA, Geier MR. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuroendocrinol Lett. 2006 Aug; 27(4): 401-13.
15. Geier DA, Geier MR. A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders. Neuroendocrinol Lett. 2006 Dec; 27(6): 833-8.
16. Geier DA, Geier MR. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. Neuroendocrinol Lett. 2007 Oct 8; 28(5).
17. Gilman JT, Tuchman RF. Autism and associated behavioral disorders: pharmacotherapuutic intervention. Ann Pharmacother. 1995; 29: 47.
18. Gurney JG, McPheeters ML, Davis MM. Parental report of health conditions and health care use among children with and without autism - National Survey of Children's Health. Arch Pediatr Adolesc Med. 2006 Aug; 160(8): 825-30.
19. Howlin P. Can early interventions alter course of autism? In: Novartis Foundation. Autism: Neural basis and treatment possibilities. John Willey & Sons Ltd; 2003. p. 250-65.
20. Howlin P, Moore A. Diagnosis in autism. A survey of over 1200 patients in the UK. Autism. 1997; 1: 135.
21. Howlin P, Goode S, Hutton J, Rutter M. Adult outcome for children with autism. J Child Psychol Psychiatry. 2004 Feb; 45(2): 212-29.
22. Koenig K, et al. Autism and the pervasive developmental disorders. In: Zeanah CM, editor. Handbook of infant mental health. 2nd ed. New York: Guilford Press 2000; 298-310.
23. Kurita H. Infantile autism with speech loss before the age of thirty months. J Am Acad Child Psychiatry. 1985 Mar; 24(2): 191-6.
24. Maestro S, Muratori F, Cesari A, et al. Course of autism signs in the first year of life. Psychopatology. 2005; 38: 26-31.
25. Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics. 2004 May; 113(5): E 472-E486.
26. Mutter J, Naumann J, Schneider R, Walach H, Haley B. Mercury and autism: accelerating evidence? Neuroendocrinol Lett. 2005 Oct; 26(5): 439-46.
27. Nakayama Y, Takahashi T, Wakabayashi A, Oono H, Radford MH. Sex differences in the relationship between cortisol levels and the Empathy and Systemizing Quotients in humans. Neuroendocrinol Lett. 2007 Aug; 28(4): 445-8.
28. Ozonoff S, Miller JN. Teaching theory of mind: a new approach to social skills training for individuals with autism. J Autism Dev Disord. 1995 Aug; 25(4): 415-33.
29. Rapin J, Tuchman R. Where we are: Overview and definitions. In: Tuchman R, Rapin I, editors. Autism: A neurological disorder of early brain development. London: Mac Keith Press; 2006. p.1-18.
30. Ruble LA, Brown S. Pervasive Developmntal Disorders: Autism. In: Wolraich ML. Disorders of Development and Learning. 3rd ed. Hamilton: BC Decker Inc; 2003. p. 249-266.
31. Scott F, Baron-Cohen S, et al. The CAST (Childhood Asperger SyndromeTest). Autism. 2002; 6(1): 9-31.
32. Schopler E, Reichler RJ, DeVellis RF, et al. Toward objective classification of childhood autism: childhood Autism rating Scale (CARS). J Autism Dev Disord. 1980; 10: 91.
33. Sliwinski S, Croonenberghs J, Christophe A, Deboutte D, Maes M. Polyunsaturated fatty acids: do they have a role in the pathophysiology of autism? Neuroendocrinol Lett. 2006 Aug; 27(4): 465-71.
34. Trillingsgaard A, Sorensen EU, Nemec G, Jorgensen M. What distinguish autism spectrum disorders from other developmental disorders before the age of four years? Eur Child Adolesc Psychiatry. 2005; 14: 65-72.
35. Turner LM, Stone WL, Pozdol SL, Coonard EE. Follow-up of children with autism spectrum disorders from age 2 to age 9. Autism. 2006 May; 10(3): 243-265.
36. Wing L. Asperger's syndrome: a clinical account. Psychol Med. 1981; 11-115.
37. Wing L. The continuum of autistic disorders. In: Schiller E, Mesibov GM, editors. Diagnosis and assessment in autism. New York: Plenum Press; 1988.
38. World Health Organization. The ICD classification of mental and behavioral disorders: clinical descriptors and diagnostic guidelines. Geneva: World Health Organization; 1992, 1993.
39. Zwaigenbaum L, Bryson S, Rogers T, et al. Behavioral manifestations of autism in the first year of life. Int J Dev Neurosci. 2005 Apr-May; 23(2-3): 143-52.